With a revenue increase of 31.1% in the second quarter 2023, year on year to cumulative value of $64 million, Sorrento Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 2,142,333. The productivity of Sorrento Therapeutics Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 30 other companies have achieved higher revenue per employee. While Sorrento Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 427. Sorrento Therapeutics Inc has 30 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SRNEQ Revenue per Employee	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Revenue Change	31.1 %	-11.61 %	19.26 %	44.25 %	-15.17 %
Sales per Employee (TTM) $	2,142,333	2,023,533	2,094,667	2,010,733	1,832,800
SRNEQ's Total Ranking	# 427	# 0	# 0	# 0	# 0
Seq. Revenue Change	-7.54 %	4.21 %	-10.38 %	51.82 %	-37.66 %

SRNEQ Company Profile >> Back to SRNEQ Efficiency Comparisons >> Compare SRNEQ Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 2
Healthcare Sector	# 31
Overall Market	# 427

Revenue per Employee Statistics
High	Average	Low
$ 5,107,600	$ 1,143,302	$ 15,338
(Mar 31 2018)		(Dec 31 2013)

Financial Statements
Sorrento Therapeutics Inc 's Revenue MRQ	$ 15 Millions	Visit SRNEQ's Income Statement
Sorrento Therapeutics Inc 's Revenues TTM	$ 64 Millions	Visit SRNEQ's aggregate revenue growth
What are SRNEQ's Sales?		Visit SRNEQ's Sales by Segment

Other Ratios
Sorrento Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SRNEQ's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SRNEQ's Competitors
Revenue per Employee for SRNEQ's Suppliers
Revenue per Employee for SRNEQ's Customers

You may also want to know
SRNEQ's Sales Growth Rates	SRNEQ's Pe Price to earnings ratio	SRNEQ's Receivables Turnover Ratio	SRNEQ's Stock Quote
SRNEQ's Net Income Growth Rates	SRNEQ's Ps Price to Sales ratio	SRNEQ's Sales per Employee	SRNEQ's Asset Turnover Ratio
SRNEQ's Net Margin	SRNEQ's Pb Price to Book ratio	SRNEQ's Financial Strength Ratios	SRNEQ's Dividend Payout Ratio

Date modified: 2026-08-29T17:19:41+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2023, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2023	Number of Employees Jun 30 2023
P3 Health Partners Inc	3,555,111.55	$ 1,137.636 Million	320
Illumina Inc	3,485,937.50	$ 4,462.000 Million	1,280
Ligand Pharmaceuticals Incorporated	3,478,255.32	$ 163.478 Million	47
Pulmatrix Inc	3,461,500.00	$ 6.923 Million	2
Assertio Holdings inc	3,170,226.42	$ 168.022 Million	53
Cue Health Inc	3,137,837.50	$ 251.027 Million	80
Horizon Therapeutics Public Limited Company	2,802,652.31	$ 3,643.448 Million	1,300
Akumin Inc	2,785,288.39	$ 743.672 Million	267
Marker Therapeutics inc	2,551,141.60	$ 12.756 Million	5
Shockwave Medical Inc	2,435,154.15	$ 616.094 Million	253
Arcturus Therapeutics Holdings Inc	2,382,576.58	$ 264.466 Million	111
Moderna Inc	2,266,808.51	$ 10,654.000 Million	4,700
Tvardi Therapeutics Inc	2,264,333.33	$ 27.172 Million	12
Eagle Pharmaceuticals inc	2,201,290.60	$ 257.551 Million	117
Spero Therapeutics Inc	2,169,280.00	$ 54.232 Million	25
Sorrento Therapeutics Inc	2,142,333.33	$ 64.270 Million	30
Vystar Corporation	2,136,727.00	$ 2.137 Million	1
Scilex Holding Company	2,134,558.82	$ 72.575 Million	34
Novavax inc	2,132,647.53	$ 1,597.353 Million	749
Semler Scientific inc	2,085,580.65	$ 64.653 Million	31
Xeris Biopharma Holdings Inc	2,062,661.54	$ 134.073 Million	65
Amgen Inc	2,044,769.23	$ 26,582.000 Million	13,000
Siga Technologies Inc	1,995,315.45	$ 97.770 Million	49
Prestige Consumer Healthcare Inc	1,981,296.49	$ 1,129.339 Million	570
Seres Therapeutics Inc	1,975,303.03	$ 130.370 Million	66
Elutia Inc	1,849,384.62	$ 48.084 Million	26
Kineta Inc	1,832,750.00	$ 7.331 Million	4
Halozyme Therapeutics Inc	1,828,966.90	$ 773.653 Million	423
Intra cellular Therapies Inc	1,811,074.26	$ 365.837 Million	202
Seagen Inc	1,801,667.50	$ 2,162.001 Million	1,200

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.